Related references
Note: Only part of the references are listed.Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus and autoimmune hepatitis
Saranya Gomathy et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Eli Hatchwell et al.
FRONTIERS IN NEUROLOGY (2022)
Progressive Multifocal Leukoencephalopathy Misdiagnosed as Neuropsychiatric Systemic Lupus Erythematosus With a Catastrophic Outcome
Hussein Algahtani et al.
NEUROLOGIST (2022)
Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease
Irene Cortese et al.
NATURE REVIEWS NEUROLOGY (2021)
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review
Ting-Yuan Lan et al.
LUPUS (2021)
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions
Charles L. Bennett et al.
LANCET HAEMATOLOGY (2021)
Prevalence of progressive multifocal leukoencephalopathy (PML) in adults and children with systemic lupus erythematosus
Teja Kapoor et al.
LUPUS SCIENCE & MEDICINE (2020)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus: Clues to early diagnosis
Lai Yin Law et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML)
Amir Khalili et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2019)
T cell deficiencies as a common risk factor for drug associated progressive multifocal leukoencephalopathy
Dejan Pavlovic et al.
IMMUNOBIOLOGY (2018)
A Punctate Magnetic Resonance Imaging Pattern in a Patient with Systemic Lupus Erythematosus Is an Early Sign of Progressive Multifocal Leukoencephalopathy: A Clinicopathological Study
Junko Ishii et al.
INTERNAL MEDICINE (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned (vol 17, pg 467, 2018)
E. O. Major et al.
LANCET NEUROLOGY (2018)
A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
Yuichi Ishikawa et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
Eugene O. Major et al.
LANCET NEUROLOGY (2018)
The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era Prevention and Management
Eamonn S. Molloy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2017)
Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy
Claudia Schroeder et al.
CLINICAL IMMUNOLOGY (2017)
Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review
C. E. Henegar et al.
LUPUS (2016)
Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals
Deanna Saylor et al.
CURRENT INFECTIOUS DISEASE REPORTS (2016)
CHARGE syndrome: a review of the immunological aspects
Monica T. Y. Wong et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2015)
B cells and progressive multifocal leukoencephalopathy: search for the missing link
Deniz Durali et al.
FRONTIERS IN IMMUNOLOGY (2015)
Low frequencies of central memory CD4 T cells in progressive multifocal leukoencephalopathy
Evelyn Dubois et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma A Case Report and Literature Review
Valentina Felli et al.
NEURORADIOLOGY JOURNAL (2014)
PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section
Joseph R. Berger et al.
NEUROLOGY (2013)
Systemic Lupus Erythematosus, Progressive Multifocal Leukoencephalopathy, and T-CD4+Lymphopenia
Mariana Brandao et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis
M. A. Sahraian et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
Rachel Emma Dickinson et al.
BLOOD (2011)
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Amy P. Hsu et al.
BLOOD (2011)
CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease
Marius Strioga et al.
IMMUNOLOGY (2011)
Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy
Leslie J. Marshall et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Mutations in CHD7, Encoding a Chromatin-Remodeling Protein, Cause Idiopathic Hypogonadotropic Hypogonadism and Kallmann Syndrome
Hyung-Goo Kim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?
Eamonn S. Molloy et al.
AUTOIMMUNITY REVIEWS (2008)
Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases
O. Nived et al.
LUPUS (2008)
CHARGE syndrome:: the phenotypic spectrum of mutations in the CHD7 gene
MCJ Jongmans et al.
JOURNAL OF MEDICAL GENETICS (2006)
JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes
G Wei et al.
JOURNAL OF NEUROVIROLOGY (2000)